-
公开(公告)号：US20220151984A1
公开(公告)日：2022-05-19
申请号：US17588033
申请日：2022-01-28
发明人： He SUN , Xijun YAN , Naifeng WU , Kaijing YAN , Yonghong ZHU , Shunnan ZHANG , Xiaolin BAI , Xiaohui MA , Yi HE , Ting LI , Lei LI
IPC分类号： A61K31/357 , A61K36/82 , A61K47/24 , A61K9/48 , A61K31/205 , A61P1/16 , A61K9/16 , A61K31/355 , A61K31/683 , A61K9/08 , A61K36/488
摘要： A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.
-
2.发明申请公开(公告)号：US20210038668A1
公开(公告)日：2021-02-11
申请号：US17041795
申请日：2019-03-25
发明人： Jingyan HAN , Qingfang CHEN , Dandan HUANG , Xiaohui MA , Yi HE , Shuiping ZHOU
IPC分类号： A61K36/258 , A61K36/481 , A61P9/10 , A61K31/343 , A61K31/704
摘要： The present invention discloses a traditional Chinese medicinal composition for preventing and/or treating ischemia reperfusion injury; the traditional Chinese medicinal composition consists of salvianolic acids, Panax notoginseng saponins and total saponins of Astragalus.
-
公开(公告)号：US20180104215A1
公开(公告)日：2018-04-19
申请号：US15560560
申请日：2016-03-22
发明人： He SUN , Xijun YAN , Naifeng WU , Kaijing YAN , Yonghong ZHU , Shunnan ZHANG , Xiaolin BAI , Xiaohui MA , Yi HE , Ting LI , Lei LI
IPC分类号： A61K31/357 , A61K31/205 , A61K36/82 , A61K47/24 , A61P1/16
CPC分类号： A61K31/357 , A61K9/08 , A61K9/1617 , A61K9/1682 , A61K9/48 , A61K31/205 , A61K31/355 , A61K31/683 , A61K36/488 , A61K36/82 , A61K47/24 , A61K2236/19 , A61P1/16
摘要： A pharmaceutical composition for treating non-alcoholic fatty liver diseases. The pharmaceutical composition is prepared from 8.75-60 parts by weight of silybin, 15-65 parts by weight of phospholipid, 25-150 parts by weight of a Pu'er tea extract, and 10.425-60 parts by weight of L-carnitine.
-
公开(公告)号：US20220395539A1
公开(公告)日：2022-12-15
申请号：US17776603
申请日：2020-11-10
发明人： Yi HE , Shuiping ZHOU , Yu WANG , Yuanpeng JIN , Jinghua KANG , Zhipeng HUO , Zhijuan HUANG , Yuanxue LIU , Zhaohui SONG
IPC分类号： A61K35/36 , A61K36/355 , A61K33/06 , A61K36/65 , A61K36/744 , A61K36/539 , A61K36/739 , A61K36/484 , A61K9/00 , A61P17/06
摘要： A traditional Chinese medicine composition for treating psoriasis, a preparation method therefor and a use thereof. The traditional Chinese medicine composition comprises: water buffalo horn powder, Japanese honeysuckle flower, gypsum, red peony root, peony bark, charred cape jasmine fruit, baical skullcap root, raw garden burnet root, and liquorice root. The preparation method comprises: proportionally weighing out the baical skullcap root, the Japanese honeysuckle flower, the red peony root, the peony bark, the gypsum, the charred cape jasmine fruit, the garden burnet root and the liquorice root, adding water and decocting 1 to 3 times, each time using 4 to 10 times the amount (weight to volume ratio) of water and decocting for 0.5 to 3 hours; combining decoctions, filtering, vacuum concentrating the filtrate, drying same, adding the water buffalo horn powder and mixing until evenly distributed.
-
公开(公告)号：US20210000853A1
公开(公告)日：2021-01-07
申请号：US16976832
申请日：2019-04-04
发明人： Shiuiping ZHOU , He SUN , Yiqian ZHANG , Xiaohui MA , Jiawen SHI , Yi HE , Xinxin LI , Jing WANG , Xiaoqing LI , Lijun FAN , Jingjing ZHANG
IPC分类号： A61K31/7048 , A61K31/216 , A61K31/704 , A61K31/343 , A61K31/405 , A61P9/04
摘要： Disclosed are a pharmaceutical composition and an application thereof. The pharmaceutical composition of the present invention comprises the following components in parts by weight: 2-20 parts of phenolic acids, 0.5-5 parts of flavonoids, 0.005-0.5 part of tanshinones, 5-20 parts of saponins, and 10-18 parts of volatile oils. The pharmaceutical composition has the functions of protecting against myocardial damage and treating heart failure.
-
6.发明公开公开(公告)号：US20230390353A1
公开(公告)日：2023-12-07
申请号：US18034362
申请日：2022-09-05
发明人： He SUN , Kaijing YAN , Xiaohui MA , Shunnan ZHANG , Yi HE , Haoshu XIONG , Yongfeng ZHENG , Xinxin LI , Hongbo ZHANG , Yanmei LI , Jing WANG , Tiantian WEN , Zhipeng HUO , Lijun FAN , Wei SUN , Jianchun WANG , Nan CAI , Rui YANG , Jingjing ZHANG
IPC分类号： A61K36/537 , A61K36/258 , A61K31/495 , A61K31/045 , A61P9/10
CPC分类号： A61K36/537 , A61K36/258 , A61K31/495 , A61K31/045 , A61P9/10
摘要： The present invention provides a pharmaceutical composition for treating myocardial ischemia, comprising Salvia Miltiorrhiza medicinal material 250-700 parts by weight, Radix Notoginseng medicinal material 50-150 parts by weight, Borneolum Syntheticum 3-9 parts by weight, and ranolazine 25-100 parts by weight. According to a further aspect of the present invention, there is provided a use of a pharmaceutical composition for preparation of a medicine for prevention and/or treatment of myocardial ischemia.
-
公开(公告)号：US20180104216A1
公开(公告)日：2018-04-19
申请号：US15560583
申请日：2016-03-22
发明人： Xijun YAN , Naifeng WU , He SUN , Kaijing YAN , Yonghong ZHU , Xiaohui MA , Shunnan ZHANG , Changwen LI , Xiaolin BAI , Ting LI , Lei LI , Yi HE
IPC分类号： A61K31/357 , A61K36/82 , A61K36/488 , A61K47/24 , A61P1/16
CPC分类号： A61K31/357 , A61K9/08 , A61K9/1617 , A61K9/1682 , A61K9/48 , A61K31/205 , A61K31/355 , A61K31/683 , A61K36/488 , A61K36/82 , A61K47/24 , A61K2236/19 , A61P1/16
摘要： Disclosed are a pharmaceutical composition for treating non-alcoholic fatty liver and a method for preparing same. The composition is prepared from the following hulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, 25-200 parts of Pu'er tea extract, and 5-50 parts of radix puerariae extract.
-
公开(公告)号：US20180055817A1
公开(公告)日：2018-03-01
申请号：US15560568
申请日：2016-03-22
发明人： He SUN , Xijun YAN , Naifeng WU , Kaijing YAN , Yonghong ZHU , Shunnan ZHANG , Xiaolin BAI , Xiaohui MA , Yi HE , Ting LI , Lei LI
IPC分类号： A61K31/357 , A61K31/683 , A61K36/82 , A61K31/355 , A61K31/205 , A61K9/16
CPC分类号： A61K31/357 , A61K9/08 , A61K9/1617 , A61K9/1682 , A61K9/48 , A61K31/205 , A61K31/355 , A61K31/683 , A61K36/488 , A61K36/82 , A61K47/24 , A61K2236/19 , A61P1/16
摘要： A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.
-
公开(公告)号：US20180042893A1
公开(公告)日：2018-02-15
申请号：US15560578
申请日：2016-03-22
发明人： Naifeng WU , Xijun YAN , He SUN , Kaijirig YAN , Yonghong ZHU , Shunnan ZHANG , Xiaolin BAI , Yi HE , Xiaohni MA , Ting LI
IPC分类号： A61K31/357 , A61K47/24 , B65D81/32 , A61K36/82
CPC分类号： A61K31/357 , A61K9/0095 , A61K9/145 , A61K9/1617 , A61K9/2013 , A61K9/4858 , A61K36/82 , A61K47/24 , A61K2236/19 , B65D81/32 , A61K2300/00
摘要： A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid complex preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid complex capsule preparation and the Pu'er teat/tea product are separately packaged.
-
公开(公告)号：US20180042892A1
公开(公告)日：2018-02-15
申请号：US15560576
申请日：2016-03-22
发明人： Naifeng WU , Xijun YAN , He SUN , Kaijing YAN , Yonghong ZHU , Shunnan ZHANG , Xiaolin BAI , Yi HE , Xiaohui MA , Ting LI , Lei LI
IPC分类号： A61K31/357 , A61K36/82 , A61K47/24 , A61K9/08 , A61K9/16
摘要： Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.023 秒)
